CLINICAL_TRIALS
research
· 2024-12-12
Clinical Trial Update: Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity [Phase 2]
Summary
A Phase 2 clinical trial is evaluating oral propranolol to prevent threshold retinopathy of prematurity and is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Retinopathy of Prematurity | Phase 2 | Status: RECRUITING